Publication: 3391

Publication: 3391

Validation of a predictive model for potential response to neoadjuvant endocrine therapy (NET) in postmenopausal women with clinical stage II or III Estrogen Receptor positive (ER+) and HER2 negative (HER2-) breast cancer (BC): an Alliance ALTERNATE trial analysis. (Alliance)

DOI

URL

Google Scholar

Citation:: Cancer Res vol 81 (4 Supplement) PD2-10

Meeting Instance:: SABCS 2020
Year:: 2020
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3910

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: Genentech, AstraZeneca
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Matthew J. Ellis Vera Suman A. Marilyn Leitch Souzan Sanati Kiran Vij Gary W. Unzeitig Jeremy Hoog Mark Watson Olwen Hahn Joseph Guenther Abigail Caudle Erika Crouch Horacio Maluf Mitch Dowsett Amy Tiersten Monica Mita Wajeeha Razaq Tina J. Hieken Yang Wang Travis Dockter Jo Anne Zujewski Anna Weiss Clifford Hudis Eric P. Winer Kelly Hunt Ann H. Partridge Cynthia X. Ma Lisa A. Carey

Networks:: CA016, KY015, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-OK003, LAPS-TX011, LAPS-TX035, NEWMEXICO, NY021, NY167, TX041, TX190

Study: Alliance-A011106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: